BETHESDA, Md., Sept. 22, 2014 /PRNewswire/ -- Spherix Incorporated (SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office (USPTO) issued a new patent to the Company in the month of September that is part of a standard essential family of patents.

Spherix Logo.

The issued patent is: USRE45,121

  • Application number: US 13/728,867
  • Publication date: Sep 9, 2014
  • Filing date: Dec 27, 2012

The listed inventors of the new patent, entitled "VLAN frame format," are Paul J. Frantz and Geoffrey O. Thompson. The patent relates to the field of data communications. More specifically, the patent relates to a method and frame format for preserving in a data frame the virtual local area network (VLAN) associated with the data frame as determined by a network device from which the data frame was received when transmitting the data frame over a communications medium shared among multiple VLANs.

CEO Anthony Hayes stated, "Several recent court decisions unrelated to Spherix demonstrate the volatility associated with only having a small number of patents to assert. The issuance by the USPTO of yet another standard essential patent to Spherix helps broaden our licensing potential and gives us great monetization diversity potential. This new patent is in addition to the three standard essential patents issued to Spherix in August. We believe that our portfolio has only been strengthened in the last year, which is giving our licensing team further runway to pursue additional licensing revenue."

"In addition, we note that Huawei answered our complaint on September 8th," continued Mr. Hayes "A copy is available on the U.S. District Court website and note that Huawei did not file any counter-claims against Spherix. Finally, in our case against Verizon, the Court set a Markman date for March 16th. As with any date set in litigation, the date is subject to change."

About Spherix
Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Forward Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:
Investor Relations Contact:
Hayden IR
Brett Maas
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

Spherix Contact:
Phone: (703) 992-9325
Email: info@spherix.com
www.spherix.com

Logo - http://photos.prnewswire.com/prnh/20131104/PH08853LOGO

SOURCE Spherix Incorporated

Copyright 2014 PR Newswire

Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Alkido Pharma Charts.
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Alkido Pharma Charts.